Akums Drugs & Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Akums Drugs & Pharma	Aarti Pharmalabs	Sudeep Pharma
Operational Metrics
Pharmaceuticals
DMF Filingsby API	20.0 .	n/a	n/a
R&D as a % of Total Sales	0.7 %	n/a	2.06 %
Financials
5 yr Average ROE	-0.59 %	9.05 %	30.67 %
5yr average Equity Multiplier	3.58	1.39	1.75
5yr Average Asset Turnover Ratio	1.18	0.58	0.92
5yr Avg Net Profit Margin	1.67 %	8.95 %	20.26 %
Price to Book	2.19	3.42	9.29
P/E	21.72	29.18	48.53
5yr Avg Cash Conversion Cycle	41.09 Days	94.46 Days	57.48 Days
Inventory Days	60.56 Days	94.9 Days	44.61 Days
Days Receivable	71.09 Days	94.46 Days	119.94 Days
Days Payable	82.93 Days	76.47 Days	85.02 Days
5yr Average Interest Coverage Ratio	6.25	12.05	33.52
5yr Avg ROCE	6.7 %	12.13 %	37.68 %
5yr Avg Operating Profit Margin	6.07 %	15.5 %	27.79 %
5 yr average Debt to Equity	0.43	0.16	0.33
5yr CAGR Net Profit	22.48 %	n/a	32.99 %
5yr Average Return on Assets	1.78 %	6.11 %	18.08 %
Shareholdings
Promoter Holding	75.26 %	43.1 %	76.15 %
Share Pledged by Promoters	0.0	0.01 %	0.0
Change in Promoter Holding (3 Yrs)	0.0	-2.88 %	-23.85 %
Change in Mutual Fund Holding (3 Yrs)	6.05 %	-4.02 %	5.67 %

	Akums Drugs & Pharma	Aarti Pharmalabs	Sudeep Pharma
Product Wise Break-Up	Product Wise Break-Up CDMO 78.18 Branded and generic formulations 16.74 API 5.09 Xanthine derivatives & Intermediates 0 API and Intermediates 0 CMO/CDMO 0	Product Wise Break-Up CDMO 9.7 API 0 Branded and generic formulations 0 API 39.4 Xanthine 50.9 CDMO 0	-
Location Wise Break-Up	Location Wise Break-Up India 93.55 Outside India 6.45 North America 0 Middle East & Africa 0 Europe 0 Asia Pacific 0	Location Wise Break-Up North America 0 Europe 0 India 47.0 Outside India 0 Asia Pacific 0 Middle East & Africa 0 Others 53.0	Location Wise Break-Up North America 15.92 Europe 17.46 India 41.32 Outside India 0 Asia Pacific 13.87 Middle East & Africa 8.08 Others 3.35
Operating Profit Break-Up	Operating Profit Break-Up CDMO 88.08 Branded and generic formulations 11.92 API`s 0 Speciality ingredients 0 Pharmaceutical, food and nutrition 0	-	Operating Profit Break-Up API`s 0 Speciality ingredients 38.66 Branded and generic formulations 0 Pharmaceutical, food and nutrition 61.34 CDMO 0
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise CDMO 76.41 API`s 14.71 Branded and generic formulations 8.88 Speciality ingredients 0 Pharmaceutical, food and nutrition 0	-	Asset Break-Up - Segment Wise API`s 0 Speciality ingredients 82.42 Branded and generic formulations 0 Pharmaceutical, food and nutrition 17.58 CDMO 0